Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
暂无分享，去创建一个
L. Ruilope | M. Burnier | R. Schmieder | A. Ortiz | L. Del Vecchio | P. Mark | P. Rossignol | J. Valdivielso | R. Kreutz | F. Mallamaci | R. Ekart | P. Sarafidis | Carmine Zoccali | C. Ferro | O. Balafa | J. Halimi | A. Persu